Dr. Robert Benish, M.D.
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Years since graduation
- 46
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 70
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
FL license ME139365 -
Hospitalist Physician
FL license ME139365
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Clinch Valley Medical Center Richlands, VA
Medical groups
- Clinch Valley Physicians Associates LLC (24 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 70
- Services billed
- 126
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | 45 |
| Biopsy of large bowel using a flexible endoscope | 46 | 46 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | 16 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pantoprazole Sodium Other prescribers in Palm Bay, FL | 97 |
| Famotidine Other prescribers in Palm Bay, FL | 67 |
| Omeprazole Other prescribers in Palm Bay, FL | 56 |
| Sucralfate Other prescribers in Palm Bay, FL | 26 |
| Linzess (linaclotide) Other prescribers in Palm Bay, FL | 24 |
| Mesalamine Er (mesalamine) Other prescribers in Palm Bay, FL | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 8 payments worth $288 in total to this clinician.
| Janssen Biotech, Inc. | $150 |
|---|---|
| Exact Sciences Corporation | $83.69 |
| Ardelyx, Inc. | $19.19 |
| Phathom Pharmaceuticals, Inc. | $18.92 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.00 |
| Food and Beverage | $204 |
|---|---|
| Education | $84.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Jun 30, 2025 | Education TREMFYA · Immunology · in-kind | $84.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,878 in research payments for these studies, mostly to the institutions running them.
- A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Takeda Pharmaceuticals U.S.A., Inc. · Completed · NCT03283085
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.